Brief: Albireo announces submission of new drug application for Elobixibat in Japan

Mochida Pharmaceutical

01/02/2017 13:00

Feb 1 (Reuters) - Albireo Pharma Inc  ALBO.O  
    * Albireo announces submission of new drug application for 
Elobixibat in Japan 
    * EA Pharma plans to co-market Elobixibat in Japan with 
Mochida Pharmaceutical Co., Ltd 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nGNXNPWKWa 
Further company coverage:  ALBO.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))